BioXcel Therapeutics, Inc. (NASDAQ:BTAI) filed a Form 8-K with the Securities and Exchange Commission on February 06, 2026, disclosing a material event.
BioXcel Therapeutics, Inc.'s stock currently trades at $1.50 with a market capitalization of $45.5M. The Healthcare company's stock moved following the disclosure.
